Intellia Therapeutics - investor relations

Skip to main navigation

Menu

invest in
partner in
join
info
CRISPR/CAS9
pipeline
get in touch

stock information

Copyright Nasdaq. Minimum 15 minutes delayed.

press releases

–

Apr 23, 2018

Summary Toggle Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting

events and presentation

upcoming event

May 17, 2018
9:00 AM EDT

Intellia Therapeutics 2018 Annual Meeting of Shareholders

corporate governance

corporate governance

financial information

financial information

stock<br />
information

stock
information

investor<br />
FAQs

investor
FAQs

information<br />
request

information
request

IR<br />
contacts

IR & PR
contacts

analyst coverage

invest in

Investor Relations

investor relations
press releases
events & presentations
corporate governance
financial information
stock information
analyst coverage
investor FAQs
information request
IR & PR contacts

partner in

partnering
our partners
who to contact

join

we’re in
i’m in
join in

CRISPR/Cas9

transforming technology
how CRISPR/Cas9 works
strategy
types of edits
delivery of CRISPR/Cas9

pipeline

info

overview
leadership
eXtellia

get in touch

© Intellia Therapeutics 2018

terms of use

Menu